Protagonist Therapeutics Inc. (PTGX) Stock Holdings & Institutional Ownership

Protagonist Therapeutics Inc.

PTGX

Super Fund	Position	Shares	Curr. Value	Port. %	Activity
Farallon Capital Management	Equity	6,348,906	$669,174,692	3.83%	+3.33%
Polen Capital Management	Equity	24,337	$2,565,120	0.02%	+100%
Duquesne Family Office	Equity	159,700	$16,832	0.50%	0%

Total Shares Held: 6,532,943

Total Value Reported: $671,756,644

Average Allocation per Portfolio 1.45%

Largest Single Portfolio Allocation: 3.83%

Largest Shareholder: Farallon Capital Management

Change in Total Shares Held (Q on Q): +129,237

Percentage Change in Shares Held (Q on Q): 2.02%

Number of Current Holders: 3

Number of New Holders (Q on Q): 1

Number of Funds with Additions (Q on Q): 2

Number of Funds with Reductions (Q on Q): 1

Number of Funds Fully Divested (Q on Q): 1

Number of Funds with No Change (Q on Q): 1